{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:57:43Z","timestamp":1790848663747,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jaut.2019.04.008","type":"journal-article","created":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T02:04:34Z","timestamp":1555553074000},"page":"86-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["The identification of CCL18 as biomarker of disease activity in localized scleroderma"],"prefix":"10.1016","volume":"101","author":[{"given":"J.S.","family":"Mertens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.M.G.J.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.L.","family":"van den Hoogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Wienke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"Thurlings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.B.","family":"Seyger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.P.A.H.","family":"Hoppenreijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.A.","family":"Wijngaarde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.M.J.J.","family":"van Vlijmen-Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"van den Bogaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Giovannone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"van Wijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"van Royen-Kerkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Marut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.R.D.","family":"Radstake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jaut.2019.04.008_bib1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s40257-017-0269-x","article-title":"Morphea and eosinophilic fasciitis: an update","volume":"18","author":"Mertens","year":"2017","journal-title":"Am. J. Clin. Dermatol."},{"issue":"2","key":"10.1016\/j.jaut.2019.04.008_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaad.2010.05.045","article-title":"Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis","volume":"64","author":"Fett","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"issue":"9","key":"10.1016\/j.jaut.2019.04.008_bib3","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/art.21264","article-title":"Localized scleroderma in childhood is not just a skin disease","volume":"52","author":"Zulian","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.jaut.2019.04.008_bib4","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3899\/jrheum.130029","article-title":"Clinical features of patients with morphea and the pansclerotic subtype: a cross-sectional study from the morphea in adults and children cohort","volume":"41","author":"Kim","year":"2014","journal-title":"J. Rheumatol."},{"issue":"3","key":"10.1016\/j.jaut.2019.04.008_bib5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/rheumatology\/keh487","article-title":"Localized scleroderma is an autoimmune disorder","volume":"44","author":"Takehara","year":"2005","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.jaut.2019.04.008_bib6","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/BOR.0b013e3283641f61","article-title":"Scleroderma in children: an update","volume":"25","author":"Zulian","year":"2013","journal-title":"Curr. Opin. Rheumatol."},{"issue":"8","key":"10.1016\/j.jaut.2019.04.008_bib7","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.jid.2017.04.008","article-title":"Transcriptional and cytokine profiles identify CXCL9 as a biomarker of disease activity in morphea","volume":"137","author":"O'Brien","year":"2017","journal-title":"J. Investig. Dermatol."},{"issue":"19","key":"10.1016\/j.jaut.2019.04.008_bib8","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jaut.2019.04.008_bib9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.rdc.2015.04.002","article-title":"The pathogenesis of systemic sclerosis","volume":"41","author":"Stern","year":"2015","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"6","key":"10.1016\/j.jaut.2019.04.008_bib10","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/01.bor.0000245727.40630.c3","article-title":"Localized scleroderma","volume":"18","author":"Laxer","year":"2006","journal-title":"Curr. Opin. Rheumatol."},{"issue":"12","key":"10.1016\/j.jaut.2019.04.008_bib11","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.3899\/jrheum.081284","article-title":"The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures","volume":"36","author":"Arkachaisri","year":"2009","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.jaut.2019.04.008_bib12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/rheumatology\/kep361","article-title":"Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study","volume":"49","author":"Arkachaisri","year":"2010","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.jaut.2019.04.008_bib13","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N. Engl. J. Med."},{"issue":"9630","key":"10.1016\/j.jaut.2019.04.008_bib14","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/S0140-6736(08)60921-6","article-title":"Spinal muscular atrophy","volume":"371","author":"Lunn","year":"2008","journal-title":"Lancet (London, England)"},{"issue":"12","key":"10.1016\/j.jaut.2019.04.008_bib15","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1136\/ard.2003.016550","article-title":"Increased FcgammaRII expression and aberrant tumour necrosis factor alpha production by mature dendritic cells from patients with active rheumatoid arthritis","volume":"63","author":"Radstake","year":"2004","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.jaut.2019.04.008_bib16","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.jid.2017.11.032","article-title":"Regarding \u201ctranscriptional and cytokine profiles identify CXCL9 as a biomarker of disease activity in morphea\u201d","volume":"138","author":"Mertens","year":"2018","journal-title":"J. Investig. Dermatol."},{"issue":"3","key":"10.1016\/j.jaut.2019.04.008_bib17","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.semarthrit.2015.06.006","article-title":"Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles","volume":"45","author":"Torok","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.jaut.2019.04.008_bib18","doi-asserted-by":"crossref","first-page":"R188","DOI":"10.1186\/ar4378","article-title":"Interferon-gamma inducible protein-10 as a potential biomarker in localized scleroderma","volume":"15","author":"Magee","year":"2013","journal-title":"Arthritis Res. Ther."},{"issue":"1 Pt 1","key":"10.1016\/j.jaut.2019.04.008_bib19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0190-9622(00)90010-0","article-title":"Increased serum levels of soluble vascular cell adhesion molecule 1 and E-selectin in patients with localized scleroderma","volume":"42","author":"Yamane","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2019.04.008_bib20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cyto.2018.01.023","article-title":"CCL18 - beyond chemotaxis","volume":"109","author":"Chenivesse","year":"2018","journal-title":"Cytokine"},{"issue":"10","key":"10.1016\/j.jaut.2019.04.008_bib21","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1084\/jem.20130240","article-title":"Identification of human CCR8 as a CCL18 receptor","volume":"210","author":"Islam","year":"2013","journal-title":"J. Exp. Med."},{"issue":"6634","key":"10.1016\/j.jaut.2019.04.008_bib22","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/42716","article-title":"A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells","volume":"387","author":"Adema","year":"1997","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jaut.2019.04.008_bib23","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/jcp.22284","article-title":"Attenuation of CXCR4 responses by CCL18 in acute lymphocytic leukemia B cells","volume":"225","author":"Catusse","year":"2010","journal-title":"J. Cell. Physiol."},{"issue":"7","key":"10.1016\/j.jaut.2019.04.008_bib24","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.4049\/jimmunol.170.7.3843","article-title":"Unique regulation of CCL18 production by maturing dendritic cells","volume":"170","author":"Vulcano","year":"2003","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2019.04.008_bib25","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.4049\/jimmunol.174.3.1723","article-title":"CCL18 is expressed in atopic dermatitis and mediates skin homing of human memory T cells","volume":"174","author":"Gunther","year":"2005","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.jaut.2019.04.008_bib26","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/art.24435","article-title":"Regulation of pulmonary inflammation and fibrosis through expression of integrins alphaVbeta3 and alphaVbeta5 on pulmonary T lymphocytes","volume":"60","author":"Luzina","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.jaut.2019.04.008_bib27","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1136\/annrheumdis-2012-202814","article-title":"Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin","volume":"73","author":"Mathes","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.jaut.2019.04.008_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175835","article-title":"Sustained low peritoneal effluent CCL18 levels are associated with preservation of peritoneal membrane function in peritoneal dialysis","volume":"12","author":"Ossorio","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jaut.2019.04.008_bib29","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1164\/rccm.200808-1201OC","article-title":"Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis","volume":"179","author":"Prasse","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.jaut.2019.04.008_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116775","article-title":"Macrophage activation in acute exacerbation of idiopathic pulmonary fibrosis","volume":"10","author":"Schupp","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jaut.2019.04.008_bib31","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1183\/09031936.00004711","article-title":"Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis","volume":"38","author":"Tiev","year":"2011","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.jaut.2019.04.008_bib32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.chest.2016.03.004","article-title":"High level of chemokine CCL18 is associated with pulmonary function deterioration, lung fibrosis progression, and reduced survival in systemic sclerosis","volume":"150","author":"Hoffmann-Vold","year":"2016","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.jaut.2019.04.008_bib33","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jaad.2017.05.018","article-title":"Long-term outcome of eosinophilic fasciitis: a cross-sectional evaluation of 35 patients","volume":"77","author":"Mertens","year":"2017","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119300915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119300915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:23:31Z","timestamp":1760257411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841119300915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":33,"alternative-id":["S0896841119300915"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2019.04.008","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The identification of CCL18 as biomarker of disease activity in localized scleroderma","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2019.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}